Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

2.

Managing dyslipidemia in the high-risk patient.

Stein EA.

Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.

PMID:
11900720
[PubMed - indexed for MEDLINE]
3.

Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal.

de Lorgeril M, Salen P, Abramson J, Dodin S, Hamazaki T, Kostucki W, Okuyama H, Pavy B, Rabaeus M.

Arch Intern Med. 2010 Jun 28;170(12):1032-6. doi: 10.1001/archinternmed.2010.184. Review.

PMID:
20585068
[PubMed - indexed for MEDLINE]
4.

Rosuvastatin in the management of hyperlipidemia.

Cheng JW.

Clin Ther. 2004 Sep;26(9):1368-87. Review.

PMID:
15531000
[PubMed - indexed for MEDLINE]
5.

Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?

de Lorgeril M.

World Rev Nutr Diet. 2009;100:80-9. doi: 10.1159/000235714. Epub 2009 Aug 17. Review. No abstract available.

PMID:
19696530
[PubMed - indexed for MEDLINE]
6.

The cost-effectiveness of a new statin (rosuvastatin) in the UK NHS.

Palmer SJ, Brady AJ, Ratcliffe AE.

Int J Clin Pract. 2003 Nov;57(9):792-800. Review.

PMID:
14686571
[PubMed - indexed for MEDLINE]
7.

Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.

Nicholls SJ, Uno K, Kataoka Y.

Expert Rev Cardiovasc Ther. 2011 Nov;9(11):1383-90. doi: 10.1586/erc.11.145. Review.

PMID:
22059787
[PubMed - indexed for MEDLINE]
8.

Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA.

Barrios V, Escobar C.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1317-27. doi: 10.1586/erc.09.119. Review.

PMID:
19900015
[PubMed - indexed for MEDLINE]
9.

Lipid lowering for primary prevention.

Yusuf S, Lonn E, Bosch J.

Lancet. 2009 Apr 4;373(9670):1152-5. doi: 10.1016/S0140-6736(09)60357-3. Review. No abstract available. Erratum in: Lancet. 2009 Jul 4-2009 Jul 10;374(9683):28.

PMID:
19345816
[PubMed - indexed for MEDLINE]
10.

[Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].

Karie S, Launay-Vacher V, Deray G, Isnard-Bagnis C.

Presse Med. 2006 Feb;35(2 Pt 1):219-29. Review. French.

PMID:
16493350
[PubMed - indexed for MEDLINE]
11.

Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

Fabbri G, Maggioni AP.

Adv Ther. 2009 May;26(5):469-87. doi: 10.1007/s12325-009-0025-6. Epub 2009 May 14. Review.

PMID:
19444394
[PubMed - indexed for MEDLINE]
12.

[Treatment of chronic heart failure. The time of statins?].

Mareev VIu.

Kardiologiia. 2005;45(12):4-10. Review. Russian. No abstract available.

PMID:
16353040
[PubMed - indexed for MEDLINE]
13.

[JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].

Olsson AG.

Lakartidningen. 2009 May 20-Jun 2;106(21-22):1471-5. Review. Swedish. No abstract available.

PMID:
19579435
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk